Citigroup
XBI icon

Citigroup’s SPDR S&P Biotech ETF XBI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.06B Buy
12,753,740
+2,275,774
+22% +$189M 0.52% 17
2025
Q1
$850M Sell
10,477,966
-673,629
-6% -$54.6M 0.43% 20
2024
Q4
$1B Buy
11,151,595
+3,401,781
+44% +$306M 0.6% 11
2024
Q3
$766M Buy
7,749,814
+492,376
+7% +$48.6M 0.44% 15
2024
Q2
$673M Sell
7,257,438
-1,564,914
-18% -$145M 0.43% 24
2024
Q1
$837M Buy
8,822,352
+4,714,266
+115% +$447M 0.55% 10
2023
Q4
$367M Sell
4,108,086
-1,509,283
-27% -$135M 0.26% 27
2023
Q3
$410M Buy
5,617,369
+759,221
+16% +$55.4M 0.31% 29
2023
Q2
$404M Sell
4,858,148
-1,408,226
-22% -$117M 0.27% 30
2023
Q1
$478M Sell
6,266,374
-1,225,012
-16% -$93.4M 0.33% 20
2022
Q4
$622M Buy
7,491,386
+2,570,152
+52% +$213M 0.5% 10
2022
Q3
$390M Sell
4,921,234
-129,263
-3% -$10.3M 0.28% 28
2022
Q2
$375M Buy
5,050,497
+1,011,470
+25% +$75.1M 0.28% 29
2022
Q1
$363M Buy
4,039,027
+398,170
+11% +$35.8M 0.22% 45
2021
Q4
$408M Buy
3,640,857
+997,524
+38% +$112M 0.22% 46
2021
Q3
$332M Sell
2,643,333
-3,070,303
-54% -$386M 0.2% 55
2021
Q2
$774M Sell
5,713,636
-581,322
-9% -$78.7M 0.47% 18
2021
Q1
$854M Buy
6,294,958
+271,735
+5% +$36.9M 0.55% 12
2020
Q4
$848M Sell
6,023,223
-1,940,587
-24% -$273M 0.5% 10
2020
Q3
$887M Buy
7,963,810
+30,234
+0.4% +$3.37M 0.58% 10
2020
Q2
$888M Sell
7,933,576
-2,539,417
-24% -$284M 0.69% 10
2020
Q1
$811M Buy
10,472,993
+2,256,262
+27% +$175M 0.73% 8
2019
Q4
$781M Sell
8,216,731
-1,942,137
-19% -$185M 0.57% 9
2019
Q3
$775M Buy
10,158,868
+1,949,248
+24% +$149M 0.61% 6
2019
Q2
$720M Sell
8,209,620
-242,126
-3% -$21.2M 0.58% 7
2019
Q1
$765M Buy
8,451,746
+500,027
+6% +$45.3M 0.74% 4
2018
Q4
$571M Buy
7,951,719
+2,301,333
+41% +$165M 0.58% 7
2018
Q3
$542M Sell
5,650,386
-17,823
-0.3% -$1.71M 0.48% 9
2018
Q2
$540M Sell
5,668,209
-820,024
-13% -$78.1M 0.5% 8
2018
Q1
$570M Buy
6,488,233
+186,469
+3% +$16.4M 0.47% 11
2017
Q4
$535M Buy
6,301,764
+1,395,984
+28% +$118M 0.43% 7
2017
Q3
$425M Sell
4,905,780
-1,838,302
-27% -$159M 0.35% 10
2017
Q2
$521M Buy
6,744,082
+1,910,329
+40% +$147M 0.47% 7
2017
Q1
$335M Buy
4,833,753
+1,015,676
+27% +$70.4M 0.3% 20
2016
Q4
$226M Sell
3,818,077
-4,458,311
-54% -$264M 0.2% 38
2016
Q3
$549M Buy
8,276,388
+2,504,448
+43% +$166M 0.51% 6
2016
Q2
$312M Buy
5,771,940
+2,724,343
+89% +$147M 0.32% 17
2016
Q1
$157M Buy
3,047,597
+264,232
+9% +$13.7M 0.18% 41
2015
Q4
$195M Sell
2,783,365
-67,495
-2% -$4.73M 0.19% 39
2015
Q3
$177M Buy
2,850,860
+1,591,407
+126% +$99.1M 0.17% 42
2015
Q2
$318M Buy
1,259,453
+297,879
+31% +$75.1M 0.28% 21
2015
Q1
$217M Buy
961,574
+503,462
+110% +$114M 0.21% 41
2014
Q4
$85.5M Buy
458,112
+96,042
+27% +$17.9M 0.08% 123
2014
Q3
$56.5M Sell
362,070
-196,510
-35% -$30.6M 0.05% 162
2014
Q2
$86M Buy
558,580
+20,806
+4% +$3.21M 0.08% 126
2014
Q1
$76.6M Sell
537,774
-19,051
-3% -$2.71M 0.08% 112
2013
Q4
$72.5M Buy
556,825
+244,165
+78% +$31.8M 0.07% 142
2013
Q3
$40.4M Sell
312,660
-546,569
-64% -$70.6M 0.04% 231
2013
Q2
$89.6M Buy
+859,229
New +$89.6M 0.09% 105